# Sublingual Sufentanil Tablet System (SSTS) Versus Intravenous Patient Controlled Analgesia After Back Surgery.

> **NCT03036514** · NA · COMPLETED · sponsor: **University Hospital, Antwerp** · enrollment: 27 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DEVICE:** Sublingual sufentanil tablet system
- **DRUG:** Patient-controlled intravenous analgesia

## Key facts

- **NCT ID:** NCT03036514
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-05
- **Primary completion:** 2019-08-01
- **Final completion:** 2019-09-01
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2020-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03036514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03036514, "Sublingual Sufentanil Tablet System (SSTS) Versus Intravenous Patient Controlled Analgesia After Back Surgery.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03036514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*